Silence Therapeutics (SLN) Other Working Capital Changes (2024 - 2026)
Silence Therapeutics (SLN) posted Other Working Capital Changes of -$404000.0 for Q1 2026, down 114.89% sequentially from -$188000.0 in Q4 2025, and down 461.11% YoY from $111876.9 in Q1 2025.
Silence Therapeutics (SLN) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Other Working Capital Changes for 3 years, with the latest figure at -$404000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 461.11% year-over-year to -$404000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$666000.0 (down 163.24% YoY) and the FY2025 annual result came in at -$334000.0, down 102.42% from the prior year.
- Other Working Capital Changes declined to -$404000.0 in Q1 2026 per SLN's latest filing, from -$188000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.9 million in Q2 2024 and troughed at -$5.3 million in Q3 2025.
- A 3-year average of -$624111.1 and a median of -$392000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 98.64% in 2025, down 683.33% in 2025.
- Over 3 years, Other Working Capital Changes stood at -$24000.0 in 2024, then plunged by 683.33% to -$188000.0 in 2025, then plunged by 114.89% to -$404000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$404000.0, -$188000.0, and -$20000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Mn |
| Jun 30, 2026 | 2.33 Mn |
| Jun 30, 2026 | 2.33 Mn |
| Mar 31, 2026 | -931,000.00 |
| Mar 31, 2026 | -931,000.00 |
| Mar 31, 2026 | -931,000.00 |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Mar 31, 2025 | 592,000.00 |
| Mar 31, 2025 | 592,000.00 |
| Mar 31, 2025 | 592,000.00 |
| Dec 31, 2024 | -392,000.00 |
| Dec 31, 2024 | -392,000.00 |